Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on vasopressin release and blood pressure during hemorrhage
- PMID: 1478192
- DOI: 10.1507/endocrj1954.39.517
Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on vasopressin release and blood pressure during hemorrhage
Abstract
Whether or not 1-desamino-8-D-arginine-vasopressin (DDAVP) reduces blood pressure or affects the release of arginine vasopressin (AVP) and renin is controversial, although evidence suggests AVP and renin are important in maintaining blood pressure during hemorrhage. We therefore investigated the effect of DDAVP on endogenous release of AVP and renin and on blood pressure during hemorrhage in dogs. In the control group the hemorrhage was performed at a rate of 0.4 ml.kg-1.min-1 for 40 min from the femoral artery. The plasma AVP concentration and renin activity (PRA) increased progressively in response to the hemorrhage, from 7.5 +/- 0.5 to 40.3 +/- 7.3 pg.ml-1, and from 11.8 +/- 1.5 to 20.5 +/- 4.2 ng.ml-1.h-1, respectively, while blood pressure decreased slightly. In the DDAVP group, intravenous infusion of DDAVP (2.5 ng.kg-1.min-1 for 40 min) and hemorrhage were simultaneously performed. The plasma DDAVP concentration increased progressively to 218 +/- 21.0 pg.ml-1. There was no significant difference, however, between the control and DDAVP groups in the response of AVP, PRA and blood pressure. The results suggested that DDAVP may not affect the release of AVP and renin or blood pressure during hemorrhage.
Similar articles
-
Effects of AVP and DDAVP on plasma renin activity and electrolyte excretion in conscious dogs.Am J Physiol. 1979 Jan;236(1):F66-70. doi: 10.1152/ajprenal.1979.236.1.F66. Am J Physiol. 1979. PMID: 434155
-
DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?J Hypertens Suppl. 1983 Dec;1(2):58-61. J Hypertens Suppl. 1983. PMID: 6400119
-
Cardiovascular and renal responses to chronic vasopressin infusion.Am J Physiol. 1986 Apr;250(4 Pt 2):H584-94. doi: 10.1152/ajpheart.1986.250.4.H584. Am J Physiol. 1986. PMID: 3515969
-
Development and therapeutic potential of vasopressin synthetic analog [V4Q5]dDAVP as a novel anticancer agent.Vitam Horm. 2020;113:259-289. doi: 10.1016/bs.vh.2019.08.010. Epub 2020 Jan 13. Vitam Horm. 2020. PMID: 32138951 Review.
-
Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years.Haemophilia. 2000 Jul;6 Suppl 1:60-7. doi: 10.1046/j.1365-2516.2000.00059.x. Haemophilia. 2000. PMID: 10982270 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous